Related Experiment Video
Updated: Jul 22, 2026
09:01
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
11.2K
Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery
Munire Abudurexiti1, Yue Zhao2, Xiaoling Wang1
1College of Pharmacy, Southwest Minzu University, Chendu 610041, China.
Pharmaceutics
|July 29, 2023
Summary
Stem cell-derived extracellular vesicles (EVs) show promise for targeted drug delivery due to their natural targeting and low immunogenicity. Biomimetic nanocarriers enhance their therapeutic potential, addressing challenges in clinical application.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Regenerative Medicine
Background:
- Stem cells offer vast therapeutic potential, with their secreted extracellular vesicles (EVs) acting as natural nanocarriers for drug delivery.
- Stem cell-derived EVs possess inherent advantages like cell targeting and low immunogenicity over synthetic alternatives.
- Clinical translation of stem cells and EVs is hindered by low yield and non-standardized isolation protocols.
Purpose of the Study:
- To review the application of biomimetic nanocarriers derived from stem cells and their EVs for targeted drug delivery.
- To discuss the advantages and challenges associated with these biomimetic nanocarriers.
- To stimulate future research in this emerging field.
Main Methods:
- Literature review focusing on biomimetic nanocarriers derived from stem cells and EVs.
- Analysis of studies employing nanotechnology and bioengineering for nanocarrier development.
- Evaluation of targeted drug delivery applications and therapeutic potential.
Main Results:
- Biomimetic nanocarriers combine nanotechnology and bioengineering for enhanced drug delivery systems.
- These nanocarriers leverage the natural properties of stem cell-derived EVs for improved targeting and reduced immune response.
- Overcoming limitations of low yield and standardization is crucial for clinical advancement.
Conclusions:
- Biomimetic nanocarriers derived from stem cells and EVs represent a promising frontier in targeted drug delivery.
- Further research is needed to optimize production and standardization for clinical applications.
- This approach holds significant potential for advancing regenerative medicine and therapeutic strategies.
More Related Videos
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...